These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 2402185)

  • 1. Identification of three muscarinic receptor subtypes in rat lung using binding studies with selective antagonists.
    Fryer AD; el-Fakahany EE
    Life Sci; 1990; 47(7):611-8. PubMed ID: 2402185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
    Zhang LB; Horowitz B; Buxton IL
    Mol Pharmacol; 1991 Dec; 40(6):943-51. PubMed ID: 1758444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reserpine-induced post-receptor reduction in muscarinic-mediated airway smooth muscle contraction.
    Gardier RW; Blaxall HS; Killian LN; Cunningham J
    Life Sci; 1991; 48(18):1705-13. PubMed ID: 2020254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro.
    Okayama M; Mullol J; Baraniuk JN; Hausfeld JN; Feldman B; Merida M; Shelhamer JH; Kaliner MA
    Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A minority of muscarinic receptors mediate rabbit tracheal smooth muscle contraction.
    Mahesh VK; Nunan LM; Halonen M; Yamamura HI; Palmer JD; Bloom JW
    Am J Respir Cell Mol Biol; 1992 Mar; 6(3):279-86. PubMed ID: 1540392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
    Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB
    Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonists and agonists interactions with the muscarinic receptor of the rat large airways.
    Scott T; McMahon KK
    J Pharmacol Exp Ther; 1988 Oct; 247(1):136-42. PubMed ID: 3171971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of muscarinic receptor subtypes on human peripheral lung.
    Casale TB; Ecklund P
    J Appl Physiol (1985); 1988 Aug; 65(2):594-600. PubMed ID: 3170410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of oxomemazine for the M1 muscarinic receptors.
    Lee SW; Woo CW; Kim JG
    Arch Pharm Res; 1994 Dec; 17(6):443-51. PubMed ID: 10319156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart.
    Ehlert FJ; Delen FM; Yun SH; Friedman DJ; Self DW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):660-71. PubMed ID: 2810116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional differences in the binding of selective muscarinic receptor antagonists in rat brain: comparison with minimum-energy conformations.
    Messer WS; Ellerbrock BR; Smith DA; Hoss W
    J Med Chem; 1989 Jun; 32(6):1164-72. PubMed ID: 2724292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S; Buckley NJ; Roberts FF
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
    Evans RA; Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of the M1 muscarinic receptor subtype between peripheral lung and cerebral cortex demonstrated by the selective antagonist AF-DX 116.
    Bloom JW; Halonen M; Seaver NA; Yamamura HI
    Life Sci; 1987 Jul; 41(4):491-6. PubMed ID: 3600190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic autoreceptors of Torpedo electric organ are of the M1 subtype: evidence by radioligand binding using selective antagonists.
    Green AC; Dowdall MJ
    J Neurochem; 1992 Feb; 58(2):478-84. PubMed ID: 1729395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.